Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial

Clinical trial NCT01746147 · COMPLETED

Trial details

NCT number: NCT01746147
Sponsor: GWT-TUD GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

MDS and AML Prior to Allogeneic SCT

Start date: 2012-12-01
Primary completion: 2015-12-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.